Cargando…
Antiviral Lipid Nanocarrier Loaded with Remdesivir Effective Against SARS-CoV-2 in vitro Model
INTRODUCTION: The ongoing SARS-CoV-2 pandemic has affected public health, the economy, and society. This study reported a nanotechnology-based strategy to enhance the antiviral efficacy of the antiviral agent remdesivir (RDS). RESULTS: We developed a nanosized spherical RDS-NLC in which the RDS was...
Autores principales: | Jeon, Woo-Jin, Lee, Hong-Ki, Na, Young-Guk, Jung, Minwoo, Han, Su-Cheol, Hwang, Jeong Ho, Jung, Eunhye, Hwang, Dasom, Shin, Jin Soo, Cho, Cheong-Weon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065008/ https://www.ncbi.nlm.nih.gov/pubmed/37007987 http://dx.doi.org/10.2147/IJN.S391462 |
Ejemplares similares
-
Remdesivir-loaded bis-MPA hyperbranched dendritic nanocarriers for pulmonary delivery
por: Halevas, Eleftherios, et al.
Publicado: (2022) -
Comparison of Antiviral Activity of Gemcitabine with 2′-Fluoro-2′-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2
por: Jang, Yejin, et al.
Publicado: (2021) -
Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes
por: Choi, Seong Woo, et al.
Publicado: (2020) -
The Delivery Strategy of Paclitaxel Nanostructured Lipid Carrier Coated with Platelet Membrane
por: Bang, Ki-Hyun, et al.
Publicado: (2019) -
Systemic Design and Evaluation of Ticagrelor-Loaded Nanostructured Lipid Carriers for Enhancing Bioavailability and Antiplatelet Activity
por: Son, Gi-Ho, et al.
Publicado: (2019)